Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ZhengLi Shi

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Biosafety and Health|June 6, 2020
Human-animal interactions and bat coronavirus spillover potential among rural residents in Southern ChinaHongying Li, Emma Mendelsohn, Chen Zong, et al.
Nature Communications|August 10, 2021
Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylacticsShaojuan Zhao, Huajun Zhang, Xinglou Yang, et al.
Science Advances|March 14, 2025
SARS-related coronavirus S-protein structures reveal synergistic RBM interactions underpinning high-affinity human ACE2 bindingJingjing Wang, Yong Ma, Zimu Li, et al.
Plos Pathogens|December 26, 2024
Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe batsNelly S C Mak, Jingyan Liu, Dan Zhang, et al.
Plos Pathogens|February 25, 2026
Correction: Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe batsNelly S C Mak, Jingyan Liu, Dan Zhang, et al.
The Journal of General Virology|August 17, 2019
Detection and characterization of a novel bat-borne coronavirus in Singapore using multiple molecular approachesXiao Fang Lim, Chengfa Benjamin Lee, Sarah Marie Pascoe, et al.
Science (New York, N.Y.)|October 1, 2005
Bats are natural reservoirs of SARS-like coronavirusesWendong Li, Zhengli Shi, Meng Yu, et al.
Cell Discovery|December 9, 2022
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administrationHuan Ma, Xinghai Zhang, Weihong Zeng, et al.
Journal of Virology|March 11, 2021
SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical pneumoniaYufei Zhang, Kun Huang, Ting Wang, et al.
Virologica Sinica|January 3, 2023
Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivoQianran Wang, Lu Peng, Yanqiu Nie, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Biosafety and Health|June 6, 2020
Human-animal interactions and bat coronavirus spillover potential among rural residents in Southern ChinaHongying Li, Emma Mendelsohn, Chen Zong, et al.
Nature Communications|August 10, 2021
Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylacticsShaojuan Zhao, Huajun Zhang, Xinglou Yang, et al.
Science Advances|March 14, 2025
SARS-related coronavirus S-protein structures reveal synergistic RBM interactions underpinning high-affinity human ACE2 bindingJingjing Wang, Yong Ma, Zimu Li, et al.
Plos Pathogens|December 26, 2024
Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe batsNelly S C Mak, Jingyan Liu, Dan Zhang, et al.
Plos Pathogens|February 25, 2026
Correction: Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe batsNelly S C Mak, Jingyan Liu, Dan Zhang, et al.
The Journal of General Virology|August 17, 2019
Detection and characterization of a novel bat-borne coronavirus in Singapore using multiple molecular approachesXiao Fang Lim, Chengfa Benjamin Lee, Sarah Marie Pascoe, et al.
Science (New York, N.Y.)|October 1, 2005
Bats are natural reservoirs of SARS-like coronavirusesWendong Li, Zhengli Shi, Meng Yu, et al.
Cell Discovery|December 9, 2022
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administrationHuan Ma, Xinghai Zhang, Weihong Zeng, et al.
Journal of Virology|March 11, 2021
SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical pneumoniaYufei Zhang, Kun Huang, Ting Wang, et al.
Virologica Sinica|January 3, 2023
Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivoQianran Wang, Lu Peng, Yanqiu Nie, et al.
Pageof 10